标题
Advances in oral peptide therapeutics
作者
关键词
-
出版物
NATURE REVIEWS DRUG DISCOVERY
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2019-12-18
DOI
10.1038/s41573-019-0053-0
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Synthesis of CSK-DEX-PLGA Nanoparticles for the Oral Delivery of Exenatide to Improve Its Mucus Penetration and Intestinal Absorption
- (2019) Yina Song et al. MOLECULAR PHARMACEUTICS
- Efficacy and safety of oral basal insulin versus subcutaneous insulin glargine in type 2 diabetes: a randomised, double-blind, phase 2 trial
- (2019) Inge B Halberg et al. Lancet Diabetes & Endocrinology
- Intestinal Permeation Enhancers for Oral Delivery of Macromolecules: A Comparison between Salcaprozate Sodium (SNAC) and Sodium Caprate (C10)
- (2019) Caroline Twarog et al. Pharmaceutics
- An ingestible self-orienting system for oral delivery of macromolecules
- (2019) Alex Abramson et al. SCIENCE
- Separating host and microbiome contributions to drug pharmacokinetics and toxicity
- (2019) Michael Zimmermann et al. SCIENCE
- Osteoporosis
- (2019) Juliet E Compston et al. LANCET
- A Delivery System for Oral Administration of Proteins/Peptides Through Bile Acid Transport Channels
- (2019) Siwen Wu et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Intestinal iontophoresis from mucoadhesive patches: a strategy for oral delivery
- (2019) Amrita Banerjee et al. JOURNAL OF CONTROLLED RELEASE
- Effect of Additional Oral Semaglutide vs Sitagliptin on Glycated Hemoglobin in Adults With Type 2 Diabetes Uncontrolled With Metformin Alone or With Sulfonylurea
- (2019) Julio Rosenstock et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effect of Oral Semaglutide on the Pharmacokinetics of Lisinopril, Warfarin, Digoxin, and Metformin in Healthy Subjects
- (2019) Tine A. Bækdal et al. CLINICAL PHARMACOKINETICS
- DIABETIC GASTROPARESIS
- (2019) Adil E Bharucha et al. ENDOCRINE REVIEWS
- 54-OR: Oral Semaglutide vs. Empagliflozin Added On to Metformin Monotherapy in Uncontrolled Type 2 Diabetes: PIONEER 2
- (2019) EDUARD MONTANYA et al. DIABETES
- PIONEER 1: Randomized Clinical Trial of the Efficacy and Safety of Oral Semaglutide Monotherapy in Comparison With Placebo in Patients With Type 2 Diabetes
- (2019) Vanita R. Aroda et al. DIABETES CARE
- Oral semaglutide versus subcutaneous liraglutide and placebo in type 2 diabetes (PIONEER 4): a randomised, double-blind, phase 3a trial
- (2019) Richard Pratley et al. LANCET
- Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
- (2019) Mansoor Husain et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and safety of oral semaglutide in patients with type 2 diabetes and moderate renal impairment (PIONEER 5): a placebo-controlled, randomised, phase 3a trial
- (2019) Ofri Mosenzon et al. Lancet Diabetes & Endocrinology
- Efficacy, Safety, and Tolerability of Oral Semaglutide Versus Placebo Added to Insulin With or Without Metformin in Patients With Type 2 Diabetes: The PIONEER 8 Trial
- (2019) Bernard Zinman et al. DIABETES CARE
- Oral Semaglutide Versus Empagliflozin in Patients With Type 2 Diabetes Uncontrolled on Metformin: The PIONEER 2 Trial
- (2019) Helena W. Rodbard et al. DIABETES CARE
- Novel strategy for oral peptide delivery in incretin-based diabetes treatment
- (2019) Yining Xu et al. GUT
- A luminal unfolding microneedle injector for oral delivery of macromolecules
- (2019) Alex Abramson et al. NATURE MEDICINE
- Combination Strategy with Complexation Hydrogels and Cell-Penetrating Peptides for Oral Delivery of Insulin
- (2018) Yu Fukuoka et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Pharmacokinetics, Safety and Tolerability of Oral Semaglutide in Subjects with Renal Impairment
- (2018) Charlotte Granhall et al. CLINICAL PHARMACOKINETICS
- Multiple Oral Insulin (ORMD-0801) Doses Elicit a Cumulative Effect on Glucose Control in T2DM Patients
- (2018) ROY ELDOR et al. DIABETES
- Insulin Access and Affordability Working Group: Conclusions and Recommendations
- (2018) William T. Cefalu et al. DIABETES CARE
- Microparticles, microcapsules and microspheres: A review of recent developments and prospects for oral delivery of insulin
- (2018) Chun Y. Wong et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- The use of low molecular weight protamine to enhance oral absorption of exenatide
- (2018) Liping Zhang et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Pharmacokinetics, Safety, and Tolerability of Oral Semaglutide in Subjects With Hepatic Impairment
- (2018) Tine A. Baekdal et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Increased jejunal permeability in human obesity is revealed by a lipid challenge and is linked to inflammation and type 2 diabetes
- (2018) Laurent Genser et al. JOURNAL OF PATHOLOGY
- Oral delivery of anti-diabetes therapeutics using cell penetrating and transcytosing peptide strategies
- (2018) Sahrish Rehmani et al. PEPTIDES
- Ionic liquids for oral insulin delivery
- (2018) Amrita Banerjee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Hyperglycemia drives intestinal barrier dysfunction and risk for enteric infection
- (2018) Christoph A. Thaiss et al. SCIENCE
- Semaglutide versus dulaglutide once weekly in patients with type 2 diabetes (SUSTAIN 7): a randomised, open-label, phase 3b trial
- (2018) Richard E Pratley et al. Lancet Diabetes & Endocrinology
- Multifunctional Nanoparticles Enable Efficient Oral Delivery of Biomacromolecules via Improving Payload Stability and Regulating the Transcytosis Pathway
- (2018) Yaxian Zheng et al. ACS Applied Materials & Interfaces
- Enterically delivered insulin tregopil exhibits rapid absorption characteristics and a pharmacodynamic effect similar to human insulin in conscious dogs
- (2018) Justin M. Gregory et al. DIABETES OBESITY & METABOLISM
- Oral peptide delivery: Translational challenges due to physiological effects
- (2018) Puneet Tyagi et al. JOURNAL OF CONTROLLED RELEASE
- Impact of Insulin Tregopil and its Permeation Enhancer on Pharmacokinetics of Metformin in Healthy Volunteers: Randomized, Open-label, Placebo Controlled, Crossover Study
- (2018) Anand Khedkar et al. CTS-Clinical and Translational Science
- Long-term oral administration of Exendin-4 to control type 2 diabetes in a rat model
- (2018) Kenichi Suzuki et al. JOURNAL OF CONTROLLED RELEASE
- Non-invasive delivery strategies for biologics
- (2018) Aaron C. Anselmo et al. NATURE REVIEWS DRUG DISCOVERY
- The Activity of Peptides of the Calcitonin Family in Bone
- (2018) Dorit Naot et al. PHYSIOLOGICAL REVIEWS
- Transcellular stomach absorption of a derivatized glucagon-like peptide-1 receptor agonist
- (2018) Stephen T. Buckley et al. Science Translational Medicine
- Effect of Oral Semaglutide Compared With Placebo and Subcutaneous Semaglutide on Glycemic Control in Patients With Type 2 Diabetes
- (2017) Melanie Davies et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Discovery, characterization, and clinical development of the glucagon-like peptides
- (2017) Daniel J. Drucker et al. JOURNAL OF CLINICAL INVESTIGATION
- Rational design of polyarginine nanocapsules intended to help peptides overcoming intestinal barriers
- (2017) Zhigao Niu et al. JOURNAL OF CONTROLLED RELEASE
- Safety and efficacy of self-assembling bubble carriers stabilized with sodium dodecyl sulfate for oral delivery of therapeutic proteins
- (2017) Po-Yen Lin et al. JOURNAL OF CONTROLLED RELEASE
- Oral insulin delivery: existing barriers and current counter-strategies
- (2017) Ahmed Gedawy et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes
- (2017) Rury R. Holman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cell–Cell Junctions Organize Structural and Signaling Networks
- (2017) Miguel A. Garcia et al. Cold Spring Harbor Perspectives in Biology
- Current status of selected oral peptide technologies in advanced preclinical development and in clinical trials
- (2016) T.A.S. Aguirre et al. ADVANCED DRUG DELIVERY REVIEWS
- Intestinal permeation enhancers for oral peptide delivery
- (2016) Sam Maher et al. ADVANCED DRUG DELIVERY REVIEWS
- Oral absorption of peptides and nanoparticles across the human intestine: Opportunities, limitations and studies in human tissues
- (2016) P. Lundquist et al. ADVANCED DRUG DELIVERY REVIEWS
- A randomized, double-blind, multicenter, placebo-controlled study to evaluate the efficacy and safety of oral salmon calcitonin in the treatment of osteoporosis in postmenopausal women taking calcium and vitamin D
- (2016) Kim Henriksen et al. BONE
- Lysosomal solute carrier transporters gain momentum in research
- (2016) B Bissa et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Self-reported Barriers to Adherence and Persistence to Treatment With Injectable Medications for Type 2 Diabetes
- (2016) C. Victor Spain et al. CLINICAL THERAPEUTICS
- Enhancement of oral insulin bioavailability: in vitro and in vivo assessment of nanoporous stimuli-responsive hydrogel microparticles
- (2016) Naveed Ahmad et al. Expert Opinion on Drug Delivery
- Pharmacodynamics and pharmacokinetics of oral salmon calcitonin in the treatment of osteoporosis
- (2016) Leonardo Bandeira et al. Expert Opinion on Drug Metabolism & Toxicology
- Preparation and in vivo evaluation of an orally available enteric-microencapsulated parathyroid hormone (1-34)-deoxycholic acid nanocomplex
- (2016) Jin Woo Park et al. International Journal of Nanomedicine
- Enhancing insulin oral absorption by using mucoadhesive nanoparticles loaded with LMWP-linked insulin conjugates
- (2016) Jianyong Sheng et al. JOURNAL OF CONTROLLED RELEASE
- Overcoming the Diffusion Barrier of Mucus and Absorption Barrier of Epithelium by Self-Assembled Nanoparticles for Oral Delivery of Insulin
- (2015) Wei Shan et al. ACS Nano
- Contrasting Effects of Lixisenatide and Liraglutide on Postprandial Glycemic Control, Gastric Emptying, and Safety Parameters in Patients With Type 2 Diabetes on Optimized Insulin Glargine With or Without Metformin: A Randomized, Open-Label Trial
- (2015) Juris J. Meier et al. DIABETES CARE
- Randomized Clinical Trial Comparing Basal Insulin Peglispro and Insulin Glargine in Patients With Type 2 Diabetes Previously Treated With Basal Insulin: IMAGINE 5
- (2015) John B. Buse et al. DIABETES CARE
- Upper gastrointestinal motility and symptoms in individuals with diabetes, prediabetes and normal glucose tolerance
- (2015) Georgios C. Boronikolos et al. DIABETOLOGIA
- Effective incorporation of insulin in mucus permeating self-nanoemulsifying drug delivery systems
- (2015) Theodora Karamanidou et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Steric and interactive barrier properties of intestinal mucus elucidated by particle diffusion and peptide permeation
- (2015) Marie Boegh et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Safety and Efficacy of Oral Octreotide in Acromegaly: Results of a Multicenter Phase III Trial
- (2015) Shlomo Melmed et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Semaglutide, a once-weekly human GLP-1 analog, does not reduce the bioavailability of the combined oral contraceptive, ethinylestradiol/levonorgestrel
- (2015) Christoph Kapitza et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Improved oral absorption of exenatide using an original nanoencapsulation and microencapsulation approach
- (2015) Liat Soudry-Kochavi et al. JOURNAL OF CONTROLLED RELEASE
- Intestinal and hepatic drug transporters: pharmacokinetic, pathophysiological, and pharmacogenetic roles
- (2015) Tomohiro Terada et al. JOURNAL OF GASTROENTEROLOGY
- Discovery of the Once-Weekly Glucagon-Like Peptide-1 (GLP-1) Analogue Semaglutide
- (2015) Jesper Lau et al. JOURNAL OF MEDICINAL CHEMISTRY
- Analysis of Intra- and Intersubject Variability in Oral Drug Absorption in Human Bioequivalence Studies of 113 Generic Products
- (2015) Masahisa Sugihara et al. MOLECULAR PHARMACEUTICS
- Toward Oral Delivery of Biopharmaceuticals: An Assessment of the Gastrointestinal Stability of 17 Peptide Drugs
- (2015) Jie Wang et al. MOLECULAR PHARMACEUTICS
- A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management
- (2015) Xavier Pi-Sunyer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Strategic Approaches to Optimizing Peptide ADME Properties
- (2014) Li Di AAPS Journal
- Mucus as a Barrier to Drug Delivery - Understanding and Mimicking the Barrier Properties
- (2014) Marie Boegh et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- Oral Druggable Space beyond the Rule of 5: Insights from Drugs and Clinical Candidates
- (2014) Bradley Croy Doak et al. CHEMISTRY & BIOLOGY
- Diabetes Insipidus: Celebrating a Century of Vasopressin Therapy
- (2014) Sana Qureshi et al. ENDOCRINOLOGY
- A Novel Suspension Formulation Enhances Intestinal Absorption of Macromolecules Via Transient and Reversible Transport Mechanisms
- (2014) Shmuel Tuvia et al. PHARMACEUTICAL RESEARCH
- Pharmacokinetics of Oral Recombinant Human Parathyroid Hormone [rhPTH(1–31)NH2] in Postmenopausal Women with Osteoporosis
- (2013) Amy Sturmer et al. CLINICAL PHARMACOKINETICS
- Mucoadhesive intestinal devices for oral delivery of salmon calcitonin
- (2013) Vivek Gupta et al. JOURNAL OF CONTROLLED RELEASE
- Human colonic mucus is a reservoir for antimicrobial peptides
- (2013) Lena Antoni et al. Journal of Crohns & Colitis
- The gastrointestinal mucus system in health and disease
- (2013) Malin E. V. Johansson et al. Nature Reviews Gastroenterology & Hepatology
- Glucose-Reducing Effect of the ORMD-0801 Oral Insulin Preparation in Patients with Uncontrolled Type 1 Diabetes: A Pilot Study
- (2013) Roy Eldor et al. PLoS One
- Mucus Enhances Gut Homeostasis and Oral Tolerance by Delivering Immunoregulatory Signals
- (2013) M. Shan et al. SCIENCE
- Efficacy and safety of recombinant human parathyroid hormone (1–84) in hypoparathyroidism (REPLACE): a double-blind, placebo-controlled, randomised, phase 3 study
- (2013) Michael Mannstadt et al. Lancet Diabetes & Endocrinology
- The single dose pharmacokinetic profile of a novel oral human parathyroid hormone formulation in healthy postmenopausal women
- (2012) Sibylle P. Hämmerle et al. BONE
- Evaluation of the efficacy, safety and pharmacokinetic profile of oral recombinant human parathyroid hormone [rhPTH(1–31)NH2] in postmenopausal women with osteoporosis
- (2012) K. Henriksen et al. BONE
- Metabolism and disposition of the oral absorption enhancer 14C-radiolabeled 8-(N-2-hydroxy-5-chlorobenzoyl)-amino-caprylic acid (5-CNAC) in healthy postmenopausal women and supplementary investigations in vitro
- (2012) Hans-Peter Gschwind et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Paracellular drug absorption enhancement through tight junction modulation
- (2012) Hendrik JR Lemmer et al. Expert Opinion on Drug Delivery
- A phase 3 trial of the efficacy and safety of oral recombinant calcitonin: The oral calcitonin in postmenopausal osteoporosis (ORACAL) trial
- (2012) Neil Binkley et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Oral Octreotide Absorption in Human Subjects: Comparable Pharmacokinetics to Parenteral Octreotide and Effective Growth Hormone Suppression
- (2012) S. Tuvia et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Oral drug delivery with polymeric nanoparticles: The gastrointestinal mucus barriers
- (2011) Laura M. Ensign et al. ADVANCED DRUG DELIVERY REVIEWS
- Zonula occludens-1 and -2 regulate apical cell structure and the zonula adherens cytoskeleton in polarized epithelia
- (2011) Alan S. Fanning et al. MOLECULAR BIOLOGY OF THE CELL
- A dose range finding study of novel oral insulin (IN-105) under fed conditions in type 2 diabetes mellitus subjects
- (2010) A. Khedkar et al. DIABETES OBESITY & METABOLISM
- Engineering and characterization of the long-acting glucagon-like peptide-1 analogue LY2189265, an Fc fusion protein
- (2010) Wolfgang Glaesner et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Liraglutide
- (2010) Daniel J. Drucker et al. NATURE REVIEWS DRUG DISCOVERY
- Intestinal barrier function: Molecular regulation and disease pathogenesis
- (2009) Katherine R. Groschwitz et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Discovery of synergistic permeation enhancers for oral drug delivery
- (2008) Kathryn Whitehead et al. JOURNAL OF CONTROLLED RELEASE
- Complexation hydrogels for intestinal delivery of interferon β and calcitonin
- (2008) Noriyasu Kamei et al. JOURNAL OF CONTROLLED RELEASE
- Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study
- (2008) Daniel J Drucker et al. LANCET
- Mechanistic Analysis of Chemical Permeation Enhancers for Oral Drug Delivery
- (2008) Kathryn Whitehead et al. PHARMACEUTICAL RESEARCH
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started